Rossari Biotech Board of Directors

Get the latest insights into the leadership at Rossari Biotech. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Edward Menezes Executive Chairman
Mr. Sunil Chari Managing Director
Mr. Aseem Dhru Independent Director
Ms. Aparna Sharma Independent Director
Ms. Esha Achan Independent Director
Mr. Gurudas Aras Independent Director

Rossari Biotech Share price

ROSSARI

625

10.05 (-1.58%)
NSE
BSE
Last updated on 4 Sep, 2025 | 15:29 IST
BUYSELL
Today's High

638.25

Today's Low

622.35

52 Week Low

569.00

52 Week High

972.70

The current prices are delayed, login to your account for live prices

Rossari Biotech FAQs

The board at Rossari Biotech consists of experienced professionals, including Mr. Edward Menezes , Mr. Sunil Chari , and others, overseeing the company’s strategic and corporate governance.

Directors at Rossari Biotech are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Edward Menezes is the current chairman at Rossari Biotech.

Executive directors at Rossari Biotech are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Rossari Biotech adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Rossari Biotech, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.